Buchumschlag

A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Cassandra Grello, Monica Demecillo, Kristyn Pierce, Sylwia Jasinski, Elizabeth Raetz, Francis Andrew De Los Reyes
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Pediatric Blood & Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
von: Alda Daniela García‐Guzmán, et al.
Veröffentlicht: (2025)

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
von: Ashley C. Holland, et al.
Veröffentlicht: (2025)

Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
von: Krunal Shah, et al.
Veröffentlicht: (2025)

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
von: Nirali N. Shah, et al.
Veröffentlicht: (2025)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
von: Andrew E. Place, et al.
Veröffentlicht: (2025)

Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study
von: Amrutha Narayana Murthy, et al.
Veröffentlicht: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
von: Mikhail Lemeshev, et al.
Veröffentlicht: (2026)

Monosomy 10 Mosaicism as an Incidental Finding in Acute Lymphoblastic Leukemia
von: Dany Assaf Curi, et al.
Veröffentlicht: (2025)

Changes in Body Composition in Children and Young People Undergoing Treatment for Acute Lymphoblastic Leukemia: A Systematic Review and Meta‐Analysis
von: Lina A. Zahed, et al.
Veröffentlicht: (2026)

Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia
von: Ashley C. Holland, et al.
Veröffentlicht: (2025)

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia
von: Kellee N. Parker, et al.
Veröffentlicht: (2026)

Caregiving for Children With Acute Lymphoblastic Leukemia Receiving Home‐Based Blinatumomab: Caregiver Experiences and Recommendations
von: Sue Zupanec, et al.
Veröffentlicht: (2025)

Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
von: Eesha A. Zaheer, et al.
Veröffentlicht: (2026)

Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study
von: Mette Tiedemann Skipper, et al.
Veröffentlicht: (2025)

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia
von: Janna R. Shapiro, et al.
Veröffentlicht: (2026)

Successful Caribbean Cooperation in Childhood Cancer Care: The Martinique—St. Lucia–Dominica Experience in the Management of Acute Lymphoblastic Leukemia
von: Julie Mascle, et al.
Veröffentlicht: (2025)

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia
von: Laura Almási, et al.
Veröffentlicht: (2026)

Disseminated Infection Following the Administration of the Varicella Vaccine in a Child with Acute Lymphoblastic Leukemia
von: Ryo Hanaki, et al.
Veröffentlicht: (2025)

Waardenburg Syndrome With T‐Lymphoblastic Lymphoma: A Case Report
von: Neha Da Rocha, et al.
Veröffentlicht: (2025)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West
von: Angela Parra del Riego, et al.
Veröffentlicht: (2026)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
von: Ankita Chakraborty, et al.
Veröffentlicht: (2026)

Venetoclax Plus Daratumumab Bridging Allo‐HSCT in Early T‐Cell Precursor Acute Lymphoblastic Leukemia
von: Fanqiao Meng, et al.
Veröffentlicht: (2025)

Attitudes Toward COVID‐19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers
von: Janna R. Shapiro, et al.
Veröffentlicht: (2025)

Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial
von: Maria C. Riccheri, et al.
Veröffentlicht: (2025)

Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels
von: Aida Zeckanovic, et al.
Veröffentlicht: (2024)

Management of Philadelphia Chromosome‐Positive B‐Lymphoblastic Leukemia Diagnosed in an Infant
von: Jessica A. O. Zimmerman, et al.
Veröffentlicht: (2025)

Secondary T‐Lymphoblastic Lymphoma With KMT2A::MAML2 Rearrangement Following Myeloid Sarcoma and RUNX1::RUNX1T1‐Positive Acute Myeloid Leukemia
von: Ting Li, et al.
Veröffentlicht: (2026)

Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana‐Farber Cancer Institute ALL Consortium Study 16‐001
von: Alexandra Thrope, et al.
Veröffentlicht: (2026)

Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments
von: Jammbe Musoro, et al.
Veröffentlicht: (2024)

Prolonged Hypogammaglobulinemia in a Child With Down Syndrome After Treatment of Acute Lymphoblastic Leukemia With Immunochemotherapy Including Blinatumomab
von: Reena Pabari, et al.
Veröffentlicht: (2025)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
von: Marko Kavcic, et al.
Veröffentlicht: (2025)

Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
von: Sheila Judge Santacroce, et al.
Veröffentlicht: (2025)

Comparing Parent and Child Reports of School Functioning as Predictors of Neurocognitive Test Performance in Hispanic/Latino Survivors of Childhood Leukemia/Lymphoblastic Lymphoma
von: Melissa Balderrama, et al.
Veröffentlicht: (2026)

Baseline Neurocognitive Functioning Among Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana Farber Cancer Institute ALL Consortium Study 16‐001
von: Sameera Ramjan, et al.
Veröffentlicht: (2025)

First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia
von: Nicolò Peccatori, et al.
Veröffentlicht: (2025)

Central Adiposity and Visceral Fat in Long‐Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Exploration of an Underappreciated Risk
von: Louise Guolla, et al.
Veröffentlicht: (2025)

Clinical Characteristics and Prognostic Risk Factors for Pediatric B‐Cell Lymphoblastic Lymphoma: A Multicenter Retrospective Cohort Study for China Net Childhood Lymphoma
von: Zhijuan Liu, et al.
Veröffentlicht: (2026)

Localized Lymphoblastic Lymphoma in Children and Adolescents: Results of the LLB‐NHL03 Trial—A Report From the Japan Children's Cancer Group
von: Masahiro Sekimizu, et al.
Veröffentlicht: (2025)

Successful Medical Management of Gastrointestinal Invasive Mucormycosis with Associated Bowel Perforation in an Adolescent Patient with pre‐B Cell Acute Lymphoblastic Leukemia
von: Heather Valdin, et al.
Veröffentlicht: (2025)

Association Between Maternal Infection During Pregnancy and the Risk of Childhood Acute Lymphoblastic Leukemia in Offspring: A Systematic Review and Meta‐Analysis
von: Xi Chen, et al.
Veröffentlicht: (2026)